Increased fixed-ratio performance and differential d- and l-amphetamine action following norepinephrine depletion by intraventricular 6-hydroxydopamine.
D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D001923:Brain Chemistry / Q000187:drug effects; D002552:Cerebral Ventricles; D003216:Conditioning, Operant / Q000187:drug effects; D003342:Corpus Striatum / Q000032:analysis; D003864:Depression, Chemical; D003913:Dextroamphetamine / Q000494:pharmacology*; D004298:Dopamine / Q000032:analysis; D005108:Extinction, Psychological / Q000187:drug effects; D006892:Hydroxydopamines / Q000008:administration & dosage / Q000494:pharmacology*; D007031:Hypothalamus / Q000032:analysis; D007267:Injections; D008297:Male; D008636:Mesencephalon / Q000032:analysis; D009043:Motor Activity / Q000187:drug effects; D009638:Norepinephrine / Q000032:analysis / Q000378:metabolism*; D051381:Rats; D012055:Reinforcement Schedule; D013329:Structure-Activity Relationship; D013997:Time Factors
D006892:Hydroxydopamines; D000661:Amphetamine; D003913:Dextroamphetamine; D004298:Dopamine; D009638:Norepinephrine